The new campus, located within the Strasbourg Teaching Hospital, is dedicated to the development of medical instrumentation and technologies and brings together surgeons, researchers, engineers and manufacturers.
The project aims to drive significant business opportunities:
- A highly dynamic medical technologies market (worth €200 billion globally with 8% annual growth), especially in the minimally invasive surgery and medical robotics sectors.
- Internationally-recognised expertise of hospital surgical teams, but lacking efficient technology transfer
- Funding and certification for University Hospital projects as part of the government-sponsored Investing for the Future programme
- The acquisition of land within the hospital area by the Urban Community
- The proximity of the German market, especially Baden-Württemberg, which is the most dynamic area in Europe for medical technologies (in terms of the number of companies and revenue).
Bringing all medical sector activities together with a single site
The Tech Med Campus will encompass patient care, research and engineering laboratories, medical training centres and enterprise parks, thereby covering the whole development cycle of medical instruments, from the design stage to their marketing.
Having private and public research laboratories located next to a hospital is a significant advantage and one of the major added values of the project. It offers easy access to expert medical knowledge and also provides facilities for clinical validation of innovation-led products.
The campus will comprise four legally-independent units, designed to complement each other
2 specialised medical institutes and 2 enterprise parks
- The Institute of Image-Guided Minimally Invasive Hybrid Surgery (MIX-Surg project), is a certified University Hospital Institute, and is part of the French government-sponsored Investing for the Future programme. The project is managed by IRCAD and will involve over 500 surgeons, researchers, engineers and manufacturers and will be the driving force of the Campus and its main attraction. Project partners include companies such as Siemens, Karl STORZ, Orange and Thales.
The main aim of MIX-Surg is to develop new surgical protocols to improve patient care, encourage technology transfer and stimulate the creation and growth of medical instrumentation start-ups.
The project will be housed in a new building connected to the IRCAD and to the new Civil Hospital and will be funded by local authorities.
- The Institute of Biomedical Implants is focused on the research and development of new implantable medical devices. The Institute is still in the project stage and is a joint component of the Institut Carnot MICA (certified by the ANR in 2011) and the I-hCARE engineering platform, certified by the Alsace competitiveness cluster
The Institute of Biomedical Implants will offer a single site to bring together specialist surgeons, academics and engineers to develop innovative new materials for biomedical implants, from the prototype stage through to tests on humans. Apart from the obvious benefits of technology transfer, the Institute will also provide a strong attraction for manufacturers keen to use its knowledge and technical facilities.
The Institute will initially be located within the Institute of Normal Anatomy.
- The Biocluster is located right next to the IRCAD and the University Hospital, on an outstanding site, the old Royal Stud farm of Louis XV. The Biocluster will provide an open-space office environment for companies of all sizes and development stages. It will not have any specific technical facilities, but is aimed especially at companies within the medical Informatics sector.
- The Technoparc will be the main zone for companies within the Campus. The park covers a total area of 30,000 m² and provides shared administrative services, such as regulatory advice and communication, and technical facilities, including a clean room and sterilisation. TheTechnoparc is being built on land bought by the CUS.